Agnete S. T. Engelsen

University of Bergen — Norway

Immunology and Microbiology · Life Sciences

17h-index3.5kcitations50works9.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(28), Pancreatic and Hepatic Oncology Research(15), Cancer Immunotherapy and Biomarkers(14), Cancer Cells and Metastasis(10), Autophagy in Disease and Therapy(6)

Publications49 total

An Organoid Model for Translational Cancer Research Recapitulates Histoarchitecture and Molecular Hallmarks of Non-Small-Cell Lung Cancer
Cancers·2025· 1 citedOpen Access
Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
Frontiers in Immunology·2025· 14 citedOpen Access
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy
Frontiers in Immunology·2024· 13 citedOpen Access
Supplementary Table S1 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Supplementary Table S2 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Supplementary Data from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Supplementary Table S1 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Data from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Supplementary Data from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Data from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Supplementary Table S2 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
2023Open Access
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway
Frontiers in Cell and Developmental Biology·2022· 12 citedOpen Access
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
Frontiers in Immunology·2022· 78 citedOpen Access
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models
Frontiers in Oncology·2022· 19 citedOpen Access
Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus
Frontiers in Cellular and Infection Microbiology·2022· 43 citedOpen Access
The Role of AXL Receptor Tyrosine Kinase in Cancer Cell Plasticity and Therapy Resistance
2022
Induction of alveolar and bronchiolar phenotypes in human lung organoids
Physiological Reports·2021· 9 citedOpen Access
Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells
Cancers·2021· 37 citedOpen Access
Role of Hypoxia-Mediated Autophagy in Tumor Cell Death and Survival
Cancers·2021· 86 citedOpen Access
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway
2020Open Access
page 1 of 3Next →

Frequent Co-authors

James B. Lorens(34), Salem Chouaı̈b(23), Gro Gausdal(22), Jean Paul Thiery(20), Stéphane Terry(17), Maria L. Lotsberg(14), Stéphanie Buart(12), Fathia Mami‐Chouaib(11), Stéphanie Corgnac(10), Kjersti Davidsen(10), Rolf A. Brekken(9), Abdérémane Abdou(9), Philippe Dessen(9), Davi Collares(9), Guillaume Meurice(9), Véronique Baud(9), Katarzyna Wnuk-Lipińska(8), Sébastien Bougnaud(8), Oddbjørn Straume(8), Linn Hodneland(8)